Literature DB >> 573381

Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology.

J P Glass, M Melamed, N L Chernik, J B Posner.   

Abstract

We reviewed the correlation between malignant cells in cerebrospinal fluid (CSF) (positive cytology) and pathologic findings at autopsy. The purpose was to discover: (1) the incidence of negative CSF cytology in patients with CNS malignancy, (2) the incidence of false-positive cytology, and (3) the relationship between a true-positive cytology and the distribution of malignant tumor at autopsy. Of 117 patients with CNS tumor and premortem cytologic examination of the CSF, 31 (26 percent) were positive and 86 (74 percent) were negative. Only 1 of 66 patients with tumor that did not reach the leptomeninges had a positive cytology. Of 51 patients with leptomeningeal tumor at autopsy, cytology was positive in 30 (59 percent) and negative in 21 (41 percent). Five potentially "false-positive" cytologies were encountered: three patients were treated, and tumor may have been eradicated; in two patients with lymphoma, inflammatory cells associated with infection were apparently mistaken for malignant cells. These data indicate that a positive CSF cytology is a reliable indicator of CNS malignancy and almost always reflects leptomeningeal tumor.

Entities:  

Mesh:

Year:  1979        PMID: 573381     DOI: 10.1212/wnl.29.10.1369

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  96 in total

1.  Evaluation and treatment of chronic meningitis.

Authors:  Kelly J Baldwin; Joseph R Zunt
Journal:  Neurohospitalist       Date:  2014-10

Review 2.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

Review 3.  Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.

Authors:  Stacey L Berg; Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 4.  Leptomeningeal Carcinomatosis in Esophageal Cancer: Case Report and Review of Literature.

Authors:  Amardeep Singh Aulakh; Amanpreet Buttar; Bilal Piperdi
Journal:  J Gastrointest Cancer       Date:  2012-09

5.  Brain metastasis and leptomeningeal carcinomatosis in a patient with cholangiocarcinoma.

Authors:  Basem M William; Jean L Grem
Journal:  Gastrointest Cancer Res       Date:  2011-07

6.  Numb chin syndrome secondary to leptomeningeal carcinomatosis from gastric adenocarcinoma.

Authors:  Vincent J Riesgo; Silvia R Delgado; Julio Poveda; Kottil Rammohan
Journal:  J Gastrointest Oncol       Date:  2015-04

7.  The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms.

Authors:  Judy Pang; Anuradha Banerjee; Tarik Tihan
Journal:  J Neurooncol       Date:  2007-11-07       Impact factor: 4.130

8.  A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.

Authors:  E Le Rhun; S Taillibert; F Zairi; N Kotecki; P Devos; A Mailliez; V Servent; L Vanlemmens; P Vennin; T Boulanger; M C Baranzelli; C André; G Marliot; J L Cazin; F Dubois; R Assaker; J Bonneterre; M C Chamberlain
Journal:  J Neurooncol       Date:  2013-03-01       Impact factor: 4.130

9.  CSF CA 15-3 in breast cancer-related leptomeningeal metastases.

Authors:  Emilie Le Rhun; Andrew Kramar; Sophie Salingue; Marie Girot; Isabelle Rodrigues; Audrey Mailliez; Fahed Zairi; Edgar Bakhache; Yves Marie Robin; Sophie Taillibert; François Dubois; Jacques Bonneterre; Marc C Chamberlain
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

10.  Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.

Authors:  A Twijnstra; B W Ongerboer de Visser; A P van Zanten; A A Hart; W J Nooyen
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.